Literature DB >> 11106144

Off-label use of antipsychotic drugs.

E Weiss1, M Hummer, D Koller, H Ulmer, W W Fleischhacker.   

Abstract

Despite the fact that most antipsychotics have only been formally evaluated for the treatment of schizophreniform disorder, schizophrenia, mania, and schizoaffective disorder (defined as "classical indications"), antipsychotics are widely used for the treatment of a broad range of symptoms and disorders. In this study, 173 patients who were having their prescriptions for antipsychotics filled at local pharmacies were interviewed. In 115 patients (66.5%), an antipsychotic was prescribed for off-label indications. Patients most often stated that they took antipsychotics as a tranquilizer or an anxiolytic. Neither gender, education, duration of treatment, nor efficacy of treatment showed an influence on the prescription practices for antipsychotics. In contrast, family status and side effects showed a significant influence. A classical indication was more often found in married and widowed patients than in unmarried or divorced ones. Patients in whom antipsychotics were prescribed for the treatment of schizophrenia, schizophreniform disorder, mania, or schizoaffective disorder experienced side effects more often than others. Age was also important for the indication of antipsychotics. Classical indications of antipsychotics were most often found in patients aged 30 to 49 years. In older patients (49-70 years), antipsychotics were almost exclusively used for off-label indications. In classical indications, clozapine was used more frequently (50%) than other antipsychotics. Melperone was primarily prescribed for off-label use.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106144     DOI: 10.1097/00004714-200012000-00018

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  13 in total

1.  Varying and "atypical" indications for atypical antipsychotics.

Authors:  Corrado Barbui; Michele Tansella; Silvio Garattini
Journal:  Psychopharmacology (Berl)       Date:  2003-05-22       Impact factor: 4.530

2.  Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use.

Authors:  W Wolfgang Fleischhacker
Journal:  Psychopharmacology (Berl)       Date:  2003-05-22       Impact factor: 4.530

3.  Drug treatment modalities in psychiatric inpatient practice: a 20-year comparison.

Authors:  Corrado Barbui; Arcangelo Ciuna; Michela Nosè; Deborah Levi; Margherita Andretta; Scott B Patten; Francesco Amaddeo; Michele Tansella
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-19       Impact factor: 5.270

4.  Off-label use of contrast agents.

Authors:  P Reimer; R Vosshenrich
Journal:  Eur Radiol       Date:  2008-02-15       Impact factor: 5.315

5.  Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance.

Authors:  Philip Sugarman; Amy Mitchell; Catherine Frogley; Geoffrey L Dickens; Marco Picchioni
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

6.  Correlates and psychiatric disorders associated with psychotropic drug use in Taiwan.

Authors:  I-Chia Chien; Shin-Huey Bih; Ching-Heng Lin; Yiing-Jenq Chou; Wen-Guang Lee; Cheng-Hua Lee; Pesus Chou
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-11-20       Impact factor: 4.328

Review 7.  Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.

Authors:  James P Kelleher; Franca Centorrino; Matthew J Albert; Ross J Baldessarini
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

8.  Atypical antipsychotics for older adults: are they safe and effective as we once thought?

Authors:  Dilip V Jeste; Jeanne E Maglione
Journal:  J Comp Eff Res       Date:  2013-07       Impact factor: 1.744

9.  Use of second-generation antipsychotic agents for sleep and sedation: a provider survey.

Authors:  Eric D A Hermes; Michael Sernyak; Robert Rosenheck
Journal:  Sleep       Date:  2013-04-01       Impact factor: 5.849

Review 10.  ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.

Authors:  Dilip V Jeste; Dan Blazer; Daniel Casey; Thomas Meeks; Carl Salzman; Lon Schneider; Pierre Tariot; Kristine Yaffe
Journal:  Neuropsychopharmacology       Date:  2007-07-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.